Form 4 for BIIB Biogen
Accepted 2024-02-13 00:00:00 ET · period of report 2024-02-09 · accession 0001127602-24-004801 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-02-13 | 2024-02-09 | BIIB | Singhal Priya | Head of Development | M - OptEx | $0.00 | +1,212 | 5,309 | +30% | $0 |
| D | 2024-02-13 | 2024-02-12 | BIIB | Singhal Priya | Head of Development | S - Sale+OE | $239.45 | -419 | 4,516 | -8% | -$100.3K |
| D | 2024-02-13 | 2024-02-09 | BIIB | Singhal Priya | Head of Development | F - Tax | $240.98 | -374 | 4,935 | -7% | -$90.1K |
| D | 2024-02-13 | 2024-02-09 | BIIB | Singhal Priya | Head of Development | M - OptEx | $0.00 | -1,212 | 1,212 | -50% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-02-09 | M | A | 1,212 | $0.00 | 5,309.09 | D | — | — | |
| 2 | Common | Common Stock | 2024-02-12 | S | D | 419 | $239.45 | 4,516.09 | D | — | — | |
| 3 | Common | Common Stock | 2024-02-09 | F | D | 374 | $240.98 | 4,935.09 | D | — | — | |
| 4 | Derivative | Restricted Stock Unit | 2024-02-09 | M | D | 1,212 | $0.00 | 1,212 | D | $0.00 · — to 2025-02-10 | 1,212 Common Stock | (F1) This award was granted to the reporting person on February 10, 2022 and will vest in three equal installments on each anniversary of the grant date. |